Corbus Pharmaceuticals Holdings, Inc. Increase (Decrease) in Accrued Liabilities
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Increase (Decrease) in Accrued Liabilities of -$1.61 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-06
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$1.27M, a 172.54% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$346.00K, a 172.69% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $4.24M.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $4.92M.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $11.39M.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was -$5.61M, a 211.53% decline from fiscal 2023.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $5.03M.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was -$4.09M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.61M 10-Q · filed 2026-08-06 | $2.63M derived: sum of 3 quarters · filed 2026-08-06 | $7.55M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$346.00K 10-Q · filed 2026-05-12 | $3.90M derived: sum of 2 quarters · filed 2026-05-12 | $8.82M derived: sum of 3 quarters · filed 2026-05-12 | $10.57M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $4.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $9.17M derived: sum of 2 quarters · filed 2026-03-09 | $10.91M derived: sum of 3 quarters · filed 2026-08-06 | $11.39M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $4.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $6.67M derived: sum of 2 quarters · filed 2026-08-06 | $7.15M 10-Q · filed 2025-11-12 | $5.40M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.22M 10-Q · filed 2026-08-06 | $481.00K derived: sum of 3 quarters · filed 2026-08-06 | -$2.85M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $476.00K 10-Q · filed 2026-05-12 | -$1.27M derived: sum of 2 quarters · filed 2026-05-12 | -$4.59M derived: sum of 3 quarters · filed 2026-05-12 | -$3.50M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$5.07M derived: sum of 2 quarters · filed 2026-03-09 | -$3.98M derived: sum of 3 quarters · filed 2026-03-09 | -$5.61M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | -$3.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$2.24M derived: sum of 2 quarters · filed 2025-11-12 | -$3.87M 10-Q · filed 2025-11-12 | -$384.00K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$542.00K 10-Q · filed 2025-08-05 | $2.94M derived: sum of 3 quarters · filed 2025-08-05 | $4.07M derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | -$1.63M 10-Q · filed 2025-05-06 | -$1.63M 10-Q · filed 2024-05-07 | $1.85M derived: sum of 2 quarters · filed 2025-05-06 | $2.98M derived: sum of 3 quarters · filed 2025-05-06 | $2.93M derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $4.61M derived: sum of 2 quarters · filed 2025-03-11 | $4.56M derived: sum of 3 quarters · filed 2025-03-11 | $5.03M 10-K · filed 2025-03-11 | $5.03M 10-K · filed 2024-03-12 | |||
| 2023-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.08M derived: sum of 2 quarters · filed 2024-11-07 | $1.55M 10-Q · filed 2024-11-07 | $1.55M 10-Q · filed 2023-11-07 | $2.71M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | -$49.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $420.00K 10-Q · filed 2024-08-06 | $419.55K 10-Q · filed 2023-08-08 | $1.59M derived: sum of 3 quarters · filed 2024-08-06 | $1.70M derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | $469.05K 10-Q · filed 2024-05-07 | $1.63M derived: sum of 2 quarters · filed 2024-05-07 | $1.75M derived: sum of 3 quarters · filed 2024-05-07 | $971.80K derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $1.28M derived: sum of 2 quarters · filed 2024-03-12 | $502.75K derived: sum of 3 quarters · filed 2024-03-12 | -$4.09M 10-K · filed 2024-03-12 | ||||
| 2022-09-30 | $117.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$662.57K derived: sum of 2 quarters · filed 2023-11-07 | -$5.26M 10-Q · filed 2023-11-07 | -$8.78M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | -$779.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$5.38M 10-Q · filed 2023-08-08 | -$8.90M derived: sum of 3 quarters · filed 2023-08-08 | -$10.37M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | -$4.60M 10-Q · filed 2023-05-09 | -$8.12M derived: sum of 2 quarters · filed 2023-05-09 | -$9.59M derived: sum of 3 quarters · filed 2023-05-09 | -$12.25M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$4.99M derived: sum of 2 quarters · filed 2023-03-07 | -$7.65M derived: sum of 3 quarters · filed 2023-03-07 | -$11.91M 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | -$1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$4.12M derived: sum of 2 quarters · filed 2022-11-08 | -$8.39M 10-Q · filed 2022-11-08 | -$14.97M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$2.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$6.92M 10-Q · filed 2022-08-09 | -$13.51M derived: sum of 3 quarters · filed 2022-08-09 | -$13.06M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$4.26M 10-Q · filed 2022-05-10 | -$10.85M derived: sum of 2 quarters · filed 2022-05-10 | -$10.40M derived: sum of 3 quarters · filed 2022-05-10 | -$5.77M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | -$6.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$6.14M derived: sum of 2 quarters · filed 2022-03-08 | -$1.51M derived: sum of 3 quarters · filed 2022-03-08 | -$400.77K 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | $448.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $5.08M derived: sum of 2 quarters · filed 2021-11-12 | $6.19M 10-Q · filed 2021-11-12 | $5.26M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $4.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $5.74M 10-Q · filed 2021-08-12 | $4.81M derived: sum of 3 quarters · filed 2021-08-12 | $9.30M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $1.11M 10-Q · filed 2021-05-13 | $179.13K derived: sum of 2 quarters · filed 2021-05-13 | $4.68M derived: sum of 3 quarters · filed 2021-05-13 | $8.02M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$931.02K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $3.57M derived: sum of 2 quarters · filed 2021-03-15 | $6.91M derived: sum of 3 quarters · filed 2021-03-15 | $12.56M 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | $4.50M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-09 | $7.84M derived: sum of 2 quarters · filed 2020-11-09 | $13.49M 10-Q · filed 2020-11-09 | $15.95M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $3.34M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-31 | $8.99M 10-Q/A · filed 2020-08-31 | $11.46M derived: sum of 3 quarters · filed 2020-08-31 | $13.04M derived: sum of 4 quarters · filed 2020-08-31 | ||||
| 2019-03-31 | $5.65M 10-Q · filed 2020-05-11 | $8.11M derived: sum of 2 quarters · filed 2020-05-11 | $9.70M derived: sum of 3 quarters · filed 2020-05-11 | $9.64M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $4.05M derived: sum of 2 quarters · filed 2020-03-16 | $3.99M derived: sum of 3 quarters · filed 2020-03-16 | $5.11M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.53M derived: sum of 2 quarters · filed 2019-11-07 | $2.65M 10-Q · filed 2019-11-07 | $4.83M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$55.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.06M 10-Q · filed 2019-08-08 | $3.25M derived: sum of 3 quarters · filed 2019-08-08 | $3.10M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $1.12M 10-Q · filed 2019-05-09 | $3.30M derived: sum of 2 quarters · filed 2019-05-09 | $3.16M derived: sum of 3 quarters · filed 2019-05-09 | $3.00M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $2.04M derived: sum of 2 quarters · filed 2019-03-12 | $1.88M derived: sum of 3 quarters · filed 2019-03-12 | $1.51M 10-K · filed 2019-03-12 | ||||
| 2017-09-30 | -$147.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$303.73K derived: sum of 2 quarters · filed 2018-11-08 | -$668.29K 10-Q · filed 2018-11-08 | $219.59K derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | -$156.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$521.04K 10-Q · filed 2018-08-08 | $366.84K derived: sum of 3 quarters · filed 2018-08-08 | $790.32K derived: sum of 4 quarters · filed 2018-08-08 | ||||
| 2017-03-31 | -$364.56K 10-Q · filed 2018-05-10 | $523.32K derived: sum of 2 quarters · filed 2018-05-10 | $946.80K derived: sum of 3 quarters · filed 2018-05-10 | $1.56M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | $887.88K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $1.31M derived: sum of 2 quarters · filed 2018-03-12 | $1.93M derived: sum of 3 quarters · filed 2018-03-12 | $2.66M 10-K · filed 2018-03-12 | ||||
| 2016-09-30 | $423.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.04M derived: sum of 2 quarters · filed 2017-11-08 | $1.77M 10-Q · filed 2017-11-08 | $1.12M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-06-30 | $616.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.35M 10-Q · filed 2017-08-09 | $695.98K derived: sum of 3 quarters · filed 2018-03-12 | $1.52M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-03-31 | $732.14K 10-Q · filed 2017-05-09 | $79.01K derived: sum of 2 quarters · filed 2018-03-12 | $904.38K derived: sum of 3 quarters · filed 2018-03-12 | $1.00M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2015-12-31 | -$653.12K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $172.24K derived: sum of 2 quarters · filed 2018-03-12 | $268.29K derived: sum of 3 quarters · filed 2018-03-12 | $312.79K 10-K · filed 2018-03-12 | ||||
| 2015-09-30 | $825.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $921.41K derived: sum of 2 quarters · filed 2016-11-10 | $965.91K 10-Q · filed 2016-11-10 | $216.63K 10-Q · filed 2015-11-10 | $1.16M derived: sum of 4 quarters · filed 2016-11-10 | |||
| 2015-06-30 | $96.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $140.55K 10-Q · filed 2016-08-12 | $334.25K derived: sum of 3 quarters · filed 2016-08-12 | $252.47K derived: sum of 4 quarters · filed 2016-08-12 | ||||
| 2015-03-31 | $44.50K 10-Q · filed 2016-05-13 | $238.20K derived: sum of 2 quarters · filed 2016-05-13 | $156.42K derived: sum of 3 quarters · filed 2016-05-13 | $250.01K derived: sum of 4 quarters · filed 2016-05-13 | ||||
| 2014-12-31 | $193.71K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $111.92K derived: sum of 2 quarters · filed 2016-03-28 | $205.51K derived: sum of 3 quarters · filed 2016-03-28 | $186.00K 10-K · filed 2016-03-28 | ||||
| 2014-09-30 | -$81.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $11.81K derived: sum of 2 quarters · filed 2015-11-10 | -$7.70K 10-Q · filed 2015-11-10 | $55.39K derived: sum of 4 quarters · filed 2015-11-10 | ||||
| 2014-06-30 | $93.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $74.08K 10-Q · filed 2015-08-13 | $137.17K derived: sum of 3 quarters · filed 2015-08-13 | |||||
| 2014-03-31 | -$19.51K 10-Q · filed 2015-05-13 | $43.58K derived: sum of 2 quarters · filed 2015-05-13 | ||||||
| 2013-12-31 | $63.09K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-10 | $33.48K 10-K · filed 2015-02-10 | ||||||
| 2013-09-30 | -$29.61K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |